Atogepant

Name: Atogepant Drug Interactions
Creator: Dr. Brian Staiger, PharmD, BCPS

157 interactions 1 explained in plain English 45 cited references

Also sold as: Qulipta Qulipta®

About Atogepant

Atogepant is a calcitonin gene-related peptide receptor antagonist used to help prevent migraine headaches. Read the full Atogepant drug information page →

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 12, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Ensitrelvir Nafcillin Injection Voxilaprevir Voriconazole Voclosporin Vinblastine

1 Contraindicated 152 Major 4 Moderate

All (157) Contraindicated (1) Major (152) Moderate (4)

Moderate

Atogepant Artemether Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Atogepant Kratom Increased CYP3A substrate exposure Details Atogepant Mavacamten Camzyos Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Atogepant Rilzabrutinib Wayrilz Increased CYP3A substrate exposure and an increased risk of CYP3A substrate-related adverse reactions Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.